Evidence map›Paper›PMID 36114194›Full record

ArticleNature communications2022

Enzymatic synthesis of benzylisoquinoline alkaloids using a parallel cascade strategy and tyrosinase variants.

Yu Wang, Fabiana Subrizi, Eve M Carter, Tom D Sheppard, John M Ward, Helen C Hailes

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Plants (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Understanding the Enzyme (Journal of chemical information and modeling · 2024
    Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yu WangDepartment of Chemistry, Christopher Ingold Building, University College London, 20 Gordon Street, London, WC1H 0AJ, UK.
Fabiana SubriziDepartment of Chemistry, Christopher Ingold Building, University College London, 20 Gordon Street, London, WC1H 0AJ, UK.ORCID 0000-0002-7082-5775
Eve M CarterDepartment of Chemistry, Christopher Ingold Building, University College London, 20 Gordon Street, London, WC1H 0AJ, UK.ORCID 0000-0002-0896-6884
Tom D SheppardDepartment of Chemistry, Christopher Ingold Building, University College London, 20 Gordon Street, London, WC1H 0AJ, UK.ORCID 0000-0002-3455-1164
John M WardDepartment of Biochemical Engineering, Bernard Katz Building, University College London, London, WC1E 6BT, UK.ORCID 0000-0002-4415-5544
Helen C HailesDepartment of Chemistry, Christopher Ingold Building, University College London, 20 Gordon Street, London, WC1H 0AJ, UK. h.c.hailes@ucl.ac.uk.ORCID 0000-0001-5574-4742
University College London · GB

Funding

Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
Biotechnology and Biological Sciences Research Council BB/R021643/1NIGMS NIH HHS P41 GM103311
6 · The paper itself

Abstract

Benzylisoquinoline alkaloid derived pharmaceuticals are widely applied in modern medicines. Recent studies on the microbial production of benzylisoquinolines have highlighted key biological syntheses towards these natural products. Routes to non-natural benzylisoquinolines have been less explored, particularly halogenated compounds which are more challenging. Here, we show the use of a tyrosinase, tyrosine decarboxylase, transaminase, and norcoclaurine synthase which are combined in a parallel cascade design, in order to generate halogenated benzylisoquinoline alkaloids in high enantiomeric excess. Notably, mutagenesis studies are applied to generate tyrosinase mutants, which enhance the acceptance of halogenated tyrosines for use in the biocatalytic cascades developed.

Indexed as

AlkaloidsBenzylisoquinolinesBiological ProductsMonophenol MonooxygenasePharmaceutical PreparationsTransaminasesTyrosine DecarboxylaseAlkaloidsBenzylisoquinolinesBiological ProductsMonophenol MonooxygenasePharmaceutical PreparationsTransaminasesTyrosine Decarboxylase

Identifiers

PMID36114194
PMCPMC9481557
OpenAlexW4296059194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.